Related references
Note: Only part of the references are listed.A New Epoch in Antitrypanosomal Treatment for Chagas Disease
Caryn Bern
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers The STOP-CHAGAS Trial
Carlos A. Morillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
TcI, TcII and TcVI Trypanosoma cruzi samples from Chagas disease patients with distinct clinical forms and critical analysis of in vitro and in vivo behavior, response to treatment and infection evolution in murine model
Maykon Tavares de Oliveira et al.
ACTA TROPICA (2017)
Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei
Susan Wyllie et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Recombination-driven generation of the largest pathogen repository of antigen variants in the protozoan Trypanosoma cruzi
D. Brent Weatherly et al.
BMC GENOMICS (2016)
Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy
Michael D. Lewis et al.
CELLULAR MICROBIOLOGY (2016)
Trypanosoma cruzi Polyamine Transporter: Its Role on Parasite Growth and Survival Under Stress Conditions
Chantal Reigada et al.
JOURNAL OF MEMBRANE BIOLOGY (2016)
Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging
Amanda Fortes Francisco et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
ABCG-like transporter of Trypanosoma cruzi involved in benznidazole resistance: Gene polymorphisms disclose inter-strain intragenic recombination in hybrid isolates
Jaques Franco et al.
INFECTION GENETICS AND EVOLUTION (2015)
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy
C. A. Morillo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Chagas' Disease
Caryn Bern
NEW ENGLAND JOURNAL OF MEDICINE (2015)
CD8+ T cells in Trypanosoma cruzi infection
Rick L. Tarleton
SEMINARS IN IMMUNOPATHOLOGY (2015)
A New Experimental Model for Assessing Drug Efficacy against Trypanosoma cruzi Infection Based on Highly Sensitive In Vivo Imaging
Michael D. Lewis et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection
Michael D. Lewis et al.
CELLULAR MICROBIOLOGY (2014)
Unveiling Benznidazole's Mechanism of Action Through Overexpression of DNA Repair Proteins in Trypanosoma cruzi
Matheus Andrade Rajao et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2014)
Benznidazole-resistance in Trypanosoma cruzi: Evidence that distinct mechanisms can act in concert
Monica C. O. Campos et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2014)
Chagas Disease Cardiomyopathy: Immunopathology and Genetics
Edecio Cunha-Neto et al.
MEDIATORS OF INFLAMMATION (2014)
Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
Israel Molina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Benznidazole Biotransformation and Multiple Targets in Trypanosoma cruzi Revealed by Metabolomics
Andrea Trochine et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Pharmacokinetics of Posaconazole Within Epithelial Cells and Fungi: Insights Into Potential Mechanisms of Action During Treatment and Prophylaxis
Paolo Campoli et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Evaluation of fungal-specific fluorescent labeled echinocandin probes as diagnostic adjuncts
Ayiasha Pratt et al.
MEDICAL MYCOLOGY (2013)
Genetic dissection of drug resistance in trypanosomes
Sam Alsford et al.
PARASITOLOGY (2013)
P-glycoprotein efflux pump plays an important role in Trypanosoma cruzi drug resistance
Monica Caroline Oliveira Campos et al.
PARASITOLOGY RESEARCH (2013)
In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon
Ana P. M. Teston et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2013)
Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential Treatments
Livia de Figueiredo Diniz et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation
Belinda S. Hall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains
Sabrina Cencig et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single Population
Ana Maria Mejia et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Recent developments in sterol 14-demethylase inhibitors for Chagas disease
Frederick S. Buckner et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2012)
Chagas Disease in Non-Endemic Countries: Epidemiology, Clinical Presentation and Treatment
Jose A. Perez-Molina et al.
CURRENT INFECTIOUS DISEASE REPORTS (2012)
The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance
Peter Bouwman et al.
NATURE REVIEWS CANCER (2012)
Red-emitting luciferases for bioluminescence reporter and imaging applications
Bruce R. Branchini et al.
ANALYTICAL BIOCHEMISTRY (2010)
Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease
Margoth Moreno et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2010)
Multiple NADPH-cytochrome P450 reductases from Trypanosoma cruzi -: Suggested role on drug resistance
Patricio Portal et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2008)
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Wataru Sakai et al.
NATURE (2008)
A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes
Shane R. Wilkinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Increased expression of iron-containing superoxide dismutase-A (TcFeSOD-A) enzyme in Trypanosoma cruzi population with in vitro-induced resistance to benznidazole
Fernanda B. Nogueira et al.
ACTA TROPICA (2006)
Deletion of copies of the gene encoding old yellow enzyme (TcOYE), a NAD(P)H flavin oxidoreductase, associates with in vitro-induced benznidazole resistance in Trypanosoma cruzi
SMF Murta et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2006)
The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease
NM El-Sayed et al.
SCIENCE (2005)
Functional mapping of a trypanosome centromere by chromosome fragmentation identifies a 16-kb GC-rich transcriptional strand-switch' domain as a major feature
SO Obado et al.
GENOME RESEARCH (2005)
Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease
D Villarreal et al.
EXPERIMENTAL PARASITOLOGY (2004)
Voltammetric behavior of benznidazole at a DNA-electrochemical biosensor
MA La-Scalea et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
Share Paper
